www.oncozine.com
Open in
urlscan Pro
35.244.153.44
Public Scan
URL:
https://www.oncozine.com/
Submission: On March 04 via manual from IN — Scanned from DE
Submission: On March 04 via manual from IN — Scanned from DE
Form analysis 4 forms found in the DOM
GET https://www.oncozine.com/
<form method="get" class="td-search-form" action="https://www.oncozine.com/"> <!-- close button -->
<div class="td-search-close"> <span><i class="td-icon-close-mobile"></i></span></div>
<div role="search" class="td-search-input"> <span>Search</span> <input id="td-header-search-mob" type="text" value="" name="s" autocomplete="off"></div>
</form>POST #
<form id="loginForm" action="#" method="post">
<div class="td-login-inputs"><input class="td-login-input" autocomplete="username" type="text" name="login_email" id="login_email" value="" required=""><label for="login_email">your username</label></div>
<div class="td-login-inputs"><input class="td-login-input" autocomplete="current-password" type="password" name="login_pass" id="login_pass" value="" required=""><label for="login_pass">your password</label></div> <input type="button"
name="login_button" id="login_button" class="wpb_button btn td-login-button" value="Login">
</form>POST #
<form id="forgotpassForm" action="#" method="post">
<div class="td-login-inputs"><input class="td-login-input" type="text" name="forgot_email" id="forgot_email" value="" required=""><label for="forgot_email">your email</label></div> <input type="button" name="forgot_button" id="forgot_button"
class="wpb_button btn td-login-button" value="Send My Password">
</form>GET https://www.oncozine.com/
<form method="get" class="td-search-form" action="https://www.oncozine.com/">
<div role="search" class="td-head-form-search-wrap"> <input id="td-header-search" type="text" value="" name="s" autocomplete="off"><input class="wpb_button wpb_btn-inverse btn" type="submit" id="td-header-search-top" value="Search"></div>
</form>Text Content
* Home
* Advertisement & Sponsorship Options
* Download Our Media Kit
* Changing Physician Behavior
* Cancer A – Z
* Drug Developmemt Technologies
* A Novel Technology based on Somatic Hypermutation (SHM)
* Editorial Advisory Board
* Join Our Editorial Advisory Board
* Contact Us
* Terms and Conditions
* Publications
* SABCS and ASH 2023
* ADC Review | J. Antibody-drug Conjugates
* Resources for For Clinicians
* Drug Map (ADC)
* Peer Review Articles
* The Review
* Changing Strategies in the War on Cancer
* Changing Strategies in the War on Cancer – Episode 1
* Changing Strategies in the War on Cancer – Episode 2
* Changing Strategies in the War on Cancer – Episode 3
* Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
* Journal of CAR T-Cell Therapy
* About CAR T-cells
* Frequently Asked Questions
* Types of Articles
* Submit a Manuscript
* The Onco’Zine Brief
* The Network
* The Episodes
* How to Support The Onco’Zine Brief
* Corporate Underwriting and Sponsorship
* The Onco’Zine Dossier
* Thalidomide: A History
* Thalidomide: In the Shadow of Death
* Controversy: The involvement of Ciba AG in the development of
Thalidomide
* Thalidomide’s Secret Past: The Link with Nazi Germany
* Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in
the ‘War’ Against Cancer
* Smoking and Health
* New Surgeon General’s Report Presents the Unfiltered Truth About
Tobacco
* Smoking and the Lost Legacy of the First Surgeon General’s Report on
Smoking and Health
* Tobacco Control in the United States Has Saved 8 Million Lives In Last
50 Years
* Tobacco Companies are Finally Moving Closer to Revealing the Truth
about Smoking
* The Harmful Effects of Smoking: The Public Denial in the Early-mid
1960s
* Drug Approvals 2017 – 2020
* Oncology & Hematology – FDA Drug Approvals 2018
* Oncology & Hematology – FDA Drug Approvals 2019
* Oncology & Hematology – FDA Drug Approvals 2020
* Articles
* Latest Articles
* Expert Interviews
* Editorials and Commentaries
* Eric Rosenthal Reports
* Publications
* News
* Business & Economics
* Clinical Development
* Conference Coverage
* The Onco’Zine Brief
* The Episodes
* National Advertising
* Resources
* Membership
* Agenda
* Join Today
* Video
* Careers
Search
* About
* Advertise
* Advisory Board
* Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ONCO'ZINE
Advertisement #1
* Home
* Advertisement & Sponsorship Options
* Download Our Media Kit
* Changing Physician Behavior
* Cancer A – Z
* Drug Developmemt Technologies
* A Novel Technology based on Somatic Hypermutation (SHM)
* Editorial Advisory Board
* Join Our Editorial Advisory Board
* Contact Us
* Terms and Conditions
* Publications
* SABCS and ASH 2023
* ADC Review | J. Antibody-drug Conjugates
* Resources for For Clinicians
* Drug Map (ADC)
* Peer Review Articles
* The Review
* Changing Strategies in the War on Cancer
* Changing Strategies in the War on Cancer – Episode 1
* Changing Strategies in the War on Cancer – Episode 2
* Changing Strategies in the War on Cancer – Episode 3
* Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
* Journal of CAR T-Cell Therapy
* About CAR T-cells
* Frequently Asked Questions
* Types of Articles
* Submit a Manuscript
* The Onco’Zine Brief
* The Network
* The Episodes
* How to Support The Onco’Zine Brief
* Corporate Underwriting and Sponsorship
* The Onco’Zine Dossier
* Thalidomide: A History
* Thalidomide: In the Shadow of Death
* Controversy: The involvement of Ciba AG in the development of
Thalidomide
* Thalidomide’s Secret Past: The Link with Nazi Germany
* Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in
the ‘War’ Against Cancer
* Smoking and Health
* New Surgeon General’s Report Presents the Unfiltered Truth About
Tobacco
* Smoking and the Lost Legacy of the First Surgeon General’s Report on
Smoking and Health
* Tobacco Control in the United States Has Saved 8 Million Lives In Last
50 Years
* Tobacco Companies are Finally Moving Closer to Revealing the Truth
about Smoking
* The Harmful Effects of Smoking: The Public Denial in the Early-mid
1960s
* Drug Approvals 2017 – 2020
* Oncology & Hematology – FDA Drug Approvals 2018
* Oncology & Hematology – FDA Drug Approvals 2019
* Oncology & Hematology – FDA Drug Approvals 2020
* Articles
* Latest Articles
* Expert Interviews
* Editorials and Commentaries
* Eric Rosenthal Reports
* Publications
* News
* Business & Economics
* Clinical Development
* Conference Coverage
* The Onco’Zine Brief
* The Episodes
* National Advertising
* Resources
* Membership
* Agenda
* Join Today
* Video
* Careers
EXPERTS FORECAST: ACHIEVING CANCER HEALTH EQUITY
Neha J. Pancholi, PhD - February 29, 2024
THE IMPACT OF DCISIONRT VERSUS CLINICOPATHOLOGIC FACTORS ALONE IN PREDICTING
BENEFIT OF RADIATION
PATIENTS WITH TRANSPLANTED KIDNEYS AND SKIN CANCER MAY BENEFIT FROM NOVEL
IMMUNOTHERAPY COMBINATION
TISSUE-LOCATION-SPECIFIC TRANSCRIPTION FACTOR PLAYS PIVOTAL ROLE IN RIGHT-SIDED
COLON CANCERS
THE IMPACT OF THE ONGOING CANCER DRUG SHORTAGE CRISIS
FEATURED
EXPERTS FORECAST: ACHIEVING CANCER HEALTH EQUITY
Neha J. Pancholi, PhD - February 29, 2024
THE IMPACT OF DCISIONRT VERSUS CLINICOPATHOLOGIC FACTORS ALONE IN PREDICTING
BENEFIT OF RADIATION
Amishi Bajaj, MD - February 28, 2024
THE DIGITAL FRONTIER: 5 WAYS ONCOLOGY INFORMATICS IS ENHANCING CANCER CARE
Jesse Kaestner - January 11, 2024
A CALL-TO ACTION: ASCO’S VISION TO HELP ADVANCE PATIENT-FOCUSED AND DECENTRALIZE
CLINICAL TRIALS
Editorial Team - January 9, 2024
NAVIGATING THROUGH THE COMPLEXITIES OF BIOPHARMA: A DEEP DIVE INTO THE CLINICAL
TRIAL DELAYS
Harsha Karur Rajasimha, MS, Ph.D - December 28, 2023
ARE THE CATHOLIC CHURCH AND ITS HOSPITALS A MARRIAGE MADE IN HEAVEN?
Editorial Team - November 24, 2023
MICROBUBBLES: THE UNLIKELY KEY TO PROVIDING ACCESSIBLE AND EFFECTIVE CANCER
TREATMENTS
Brandon H. McNaughton, Ph.D. - November 23, 2023
HEALTHCARE INDUSTRY TRENDS FOR 2024
Hilton M. Hudson, MD - November 20, 2023
Advertisement
NEWS
EXPERTS FORECAST: ACHIEVING CANCER HEALTH EQUITY
Neha J. Pancholi, PhD - February 29, 2024
THE IMPACT OF DCISIONRT VERSUS CLINICOPATHOLOGIC FACTORS ALONE IN PREDICTING
BENEFIT OF RADIATION
Amishi Bajaj, MD - February 28, 2024
PATIENTS WITH TRANSPLANTED KIDNEYS AND SKIN CANCER MAY BENEFIT FROM NOVEL
IMMUNOTHERAPY COMBINATION
Editorial Team - February 28, 2024
TISSUE-LOCATION-SPECIFIC TRANSCRIPTION FACTOR PLAYS PIVOTAL ROLE IN RIGHT-SIDED
COLON CANCERS
Editorial Team - February 27, 2024
THE IMPACT OF THE ONGOING CANCER DRUG SHORTAGE CRISIS
Editorial Team - February 10, 2024
A PROTAC, CALLED NR-V04 OFFERS A NEW IMMUNOTHERAPEUTIC APPROACH TO TREAT VARIOUS
TYPES...
Editorial Team - February 9, 2024
SAFER CANCER TREATMENT: ‘HEART-ON-A-CHIP’ TESTS CHEMOTHERAPIES AND OTHER CANCER
DRUGS
Editorial Team - February 5, 2024
FORECAST 2024: BROADENING THE REACH OF CANCER VACCINES
Neha J. Pancholi, PhD - February 2, 2024
DRUG COMBINATION SHOWS PROMISE IN THE TREATMENT IN MALIGNANT PERIPHERAL NERVE
SHEATH TUMORS
Peter Hofland - January 31, 2024
IMMUNOTHERAPY AFTER SURGERY IMPROVES SURVIVAL IN PATIENTS WITH KIDNEY CANCER
Editorial Team - January 28, 2024
PIRTOBRUTINIB EXPECTED TO DOMINATE CLL BTK INHIBITOR MARKET BY 2032
Editorial Team - January 23, 2024
CALMING THE CYTOKINE STORM
Editorial Team - January 18, 2024
CONFERENCE COVERAGE
IMMUNOTHERAPY AFTER SURGERY IMPROVES SURVIVAL IN PATIENTS WITH KIDNEY CANCER
Editorial Team - January 28, 2024
LARGEST PROSPECTIVE MRNA EFFICACY TRIAL SHOWS COVID VACCINE TO BE SAFE IN SICKLE
CELL...
Peter Hofland - December 14, 2023
THE FIELD BETWEEN MATCHED AND MISMATCHED HEMATOPOIETIC CELL TRANSPLANTATION
Danielle Garcia - December 13, 2023
REVUMENIB SHOWS POSITIVE RESULTS IN THE TREATMENT OF PATIENTS WITH ACUTE
LEUKEMIAS
Danielle Garcia - December 13, 2023
MODIFIED STEM CELL TRANSPLANT SHOWS POSITIVE RESULTS IN ADULTS WITH SEVERE
SICKLE CELL DISEASE
Peter Hofland - December 12, 2023
COMBINATION OF IBRUTINIB + VENETOCLAX EFFECTIVE IN TREATMENT OF MANTLE CELL
LYMPHOMA
Peter Hofland - December 12, 2023
HEAD-TO-HEAD STUDY SUPPORTS ADDING DARATUMUMAB TO STANDARD REGIMEN IN TREATMENT
OF MULTIPLE MYELOMA
Peter Hofland - December 12, 2023
AGAVE-201 STUDY SHOWS AXATILIMAB EFFICACY AND DURABLE RESPONS IN CHRONIC
GRAFT-VERSUS-HOST DISEASE
Peter Hofland - December 12, 2023
POSITIVE PRELIMINARY DATA FOR DSP-5336 IN PATIENTS WITH RELAPSED OR REFRACTORY
ACUTE LEUKEMIA
Danielle Garcia - December 12, 2023
LINVOSELTAMAB SHOWS STRONG RATES AND DEPTH OF RESPONSE IN HEAVILY PRE-TREATED
MULTIPLE MYELOMA
Editorial Team - December 12, 2023
CAR-T IMMUNOTHERAPY REMAINS A VIABLE OPTION EVEN WHEN DISEASE GOES INTO
REMISSION BEFORE INFUSION
Editorial Team - December 11, 2023
QUIZARTINIB OFFERS IMPROVED HEALTH RELATED QUALITY OF LIFE AND MINIMAL SIDE
EFFECTS IN AML
Editorial Team - December 11, 2023
Advertisement
EDITORIAL
EXPERTS FORECAST: ACHIEVING CANCER HEALTH EQUITY
Neha J. Pancholi, PhD - February 29, 2024
THE IMPACT OF DCISIONRT VERSUS CLINICOPATHOLOGIC FACTORS ALONE IN PREDICTING
BENEFIT OF RADIATION
Amishi Bajaj, MD - February 28, 2024
FORECAST 2024: BROADENING THE REACH OF CANCER VACCINES
Neha J. Pancholi, PhD - February 2, 2024
THE DIGITAL FRONTIER: 5 WAYS ONCOLOGY INFORMATICS IS ENHANCING CANCER CARE
Jesse Kaestner - January 11, 2024
A CALL-TO ACTION: ASCO’S VISION TO HELP ADVANCE PATIENT-FOCUSED AND DECENTRALIZE
CLINICAL TRIALS
Editorial Team - January 9, 2024
NAVIGATING THROUGH THE COMPLEXITIES OF BIOPHARMA: A DEEP DIVE INTO THE CLINICAL
TRIAL DELAYS
Harsha Karur Rajasimha, MS, Ph.D - December 28, 2023
ERIC ROSENTHAL REPORTS
REMEMBERING EMIL “JAY” FREIREICH—THE MAN WHO MADE VINCE DEVITA A ‘BELIEVER’
Eric T. Rosenthal - February 13, 2021
WHY WERE TOP HHS OFFICIALS? INTERVIEWS THWARTED BY THEIR PRESS OFFICES?
Eric T. Rosenthal - March 5, 2019
EXPERT INTERVIEWS
SONALASENSE: DEVELOPING A SAFE AND EFFECTIVE NONINVASIVE TREATMENT FOR CANCER
Danielle Garcia - October 6, 2023
BE THE MATCH®: IMPROVING OUTCOMES AND PROVIDING HOPE TO PATIENTS IN NEED
Danielle Garcia - October 6, 2023
DEVELOPING A NEW STANDARD OF CARE: CANCER TREATMENT WITH PHOTOIMMUNOTHERAPY
Danielle Garcia - August 14, 2023
Advertisment #12
EXPERTS FORECAST: ACHIEVING CANCER HEALTH EQUITY
Neha J. Pancholi, PhD - February 29, 2024
THE IMPACT OF DCISIONRT VERSUS CLINICOPATHOLOGIC FACTORS ALONE IN PREDICTING
BENEFIT OF RADIATION
Amishi Bajaj, MD - February 28, 2024
PATIENTS WITH TRANSPLANTED KIDNEYS AND SKIN CANCER MAY BENEFIT FROM NOVEL
IMMUNOTHERAPY COMBINATION
Editorial Team - February 28, 2024
DAIICHI SANKYO OUT-LICENSES INVESTIGATIONAL AGENT DS-6051 TO ANHEART
THERAPEUTICS
Peter Hofland - December 19, 2018
HOW MEANINGFUL WILL CHANGES BE TO ETHICAL GUIDELINES FOLLOWING JOSE BASELGA’S
FALL?
Eric T. Rosenthal - October 9, 2018
REVERSAL OF FORTUNE: HOW A VILIFIED DRUG BECAME A LIFE-SAVING AGENT IN THE
‘WAR’...
Peter Hofland - November 30, 2013
* News2915
* Conference Coverage498
* Research & Development360
* Cancer Risk299
* Clinical Trial Updates271
* Clinical development259
* Business & Economics193
* Regulatory Updates119
* Op-Ed | Opinion108
* Editorials and Commentaries107
ABOUT US
Onco'Zine - The International Oncology Network, has been created to inform,
educate, and support physicians and healthcare professionals treating cancer
patients. The Journal reports on current research and development in oncology
and hematology and contains clinical information created specifically for
healthcare professionals.
FOLLOW US
* Home
* Advertisement & Sponsorship Options
* Download Our Media Kit
* Changing Physician Behavior
* Cancer A – Z
* Drug Developmemt Technologies
* A Novel Technology based on Somatic Hypermutation (SHM)
* Editorial Advisory Board
* Join Our Editorial Advisory Board
* Contact Us
* Terms and Conditions
* Publications
* SABCS and ASH 2023
* ADC Review | J. Antibody-drug Conjugates
* Resources for For Clinicians
* Drug Map (ADC)
* Peer Review Articles
* The Review
* Changing Strategies in the War on Cancer
* Changing Strategies in the War on Cancer – Episode 1
* Changing Strategies in the War on Cancer – Episode 2
* Changing Strategies in the War on Cancer – Episode 3
* Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
* Journal of CAR T-Cell Therapy
* About CAR T-cells
* Frequently Asked Questions
* Types of Articles
* Submit a Manuscript
* The Onco’Zine Brief
* The Network
* The Episodes
* How to Support The Onco’Zine Brief
* Corporate Underwriting and Sponsorship
* The Onco’Zine Dossier
* Thalidomide: A History
* Thalidomide: In the Shadow of Death
* Controversy: The involvement of Ciba AG in the development of
Thalidomide
* Thalidomide’s Secret Past: The Link with Nazi Germany
* Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in
the ‘War’ Against Cancer
* Smoking and Health
* New Surgeon General’s Report Presents the Unfiltered Truth About
Tobacco
* Smoking and the Lost Legacy of the First Surgeon General’s Report on
Smoking and Health
* Tobacco Control in the United States Has Saved 8 Million Lives In Last
50 Years
* Tobacco Companies are Finally Moving Closer to Revealing the Truth
about Smoking
* The Harmful Effects of Smoking: The Public Denial in the Early-mid
1960s
* Drug Approvals 2017 – 2020
* Oncology & Hematology – FDA Drug Approvals 2018
* Oncology & Hematology – FDA Drug Approvals 2019
* Oncology & Hematology – FDA Drug Approvals 2020
* Articles
* Latest Articles
* Expert Interviews
* Editorials and Commentaries
* Eric Rosenthal Reports
* Publications
* News
* Business & Economics
* Clinical Development
* Conference Coverage
* The Onco’Zine Brief
* The Episodes
* National Advertising
* Resources
* Membership
* Agenda
* Join Today
* Video
* Careers
© 2001 - 2023 Sunvalley Communication, LLC. All Rights Reserved.
X